×
Organon Net Profit Margin 2019-2025 | OGN
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Organon net profit margin from 2019 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
View More
Organon Net Profit Margin 2019-2025 | OGN
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Organon net profit margin from 2019 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$145.3B
CVS Health (CVS)
$75.4B
Elevance Health (ELV)
$64.4B
Cencora (COR)
$55.5B
DiDi Global (DIDIY)
$26B
Labcorp Holdings (LH)
$21.9B
Natera (NTRA)
$18.8B
BioMerieux (BMXMF)
$17.1B
ICON (ICLR)
$15.3B
EUROFINS SCIENT (ERFSF)
$14.9B
CochLear (CHEOY)
$13.4B
Solventum (SOLV)
$12.8B
Medpace Holdings (MEDP)
$12.7B
Revvity (RVTY)
$11.2B
Viatris (VTRS)
$10.9B
Avantor (AVTR)
$9.5B
Sonic Healthcare (SKHHY)
$9.2B
Charles River Laboratories (CRL)
$8.8B
HealthEquity (HQY)
$8.3B
Caris Life Sciences,�Inc (CAI)
$6.9B
Amplifon S.p.A (AMFPF)
$5.4B
Bausch + Lomb (BLCO)
$5.1B
BrightSpring Health Services (BTSG)
$3.6B
Sotera Health (SHC)
$3.5B
Surgery Partners (SGRY)
$2.9B
Concentras Parent (CON)
$2.6B
GeneDx Holdings (WGS)
$2.4B
Alignment Healthcare (ALHC)
$2.3B
Progyny (PGNY)
$2B
PACS (PACS)
$1.8B